Abstract

754P - Effect of second-line cabozantinib on health states for patients with advanced hepatocellular carcinoma (aHCC) after sorafenib: QTWiST analysis from the CELESTIAL study

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
131P - Cabozantinib in Asian patients with hepatocellular carcinoma and other solid tumours: Population pharmacokinetics analysis
C.-H Hsu ... L Nguyen
Annals of Oncology | VOL. 30
C.-H Hsu, et. al.C.-H Hsu ... L Nguyen
01 Nov 2019
1187PD - Phase II study of lenvatinib plus pembrolizumab for disease progression after PD-1/PD-L1 immune checkpoint inhibitor in metastatic clear cell renal cell carcinoma (mccRCC): Results of an interim analysis
A Pinto Marin ... D.A Richards
Annals of Oncology | VOL. 30
A Pinto Marin, et. al.A Pinto Marin ... D.A Richards
01 Oct 2019
Interventions for the treatment of oral cavity and oropharyngeal cancer: chemotherapy.
Janet E Clarkson ... Ambika Parmar
The Cochrane database of systematic reviews | VOL. 12
Janet E Clarkson, et. al.Janet E Clarkson ... Ambika Parmar
20 Dec 2021
Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma
Anthony B El-Khoueiry ... Alan P Venook
New England Journal of Medicine | VOL. 379
Anthony B El-Khoueiry, et. al.Anthony B El-Khoueiry ... Alan P Venook
05 Jul 2018
View more papers

More From: Annals of Oncology

Paper Title
Journal
Date
Author
Abemaciclib plus a nonsteroidal aromatase inhibitor as initial therapy for HR+, HER2− advanced breast cancer: final overall survival results of MONARCH 3
M.P Goetz ... S.R.D Johnston
Annals of Oncology | VOL. -
M.P Goetz, et. al.M.P Goetz ... S.R.D Johnston
01 May 2024
Overcoming barriers in biomarker testing. Letter to the Editor regarding: ‘ESMO study on the availability and accessibility of biomolecular technologies in oncology in Europe’, by A. Bayle et al.
J García-Foncillas ... A Stenzinger
Annals of Oncology | VOL. -
J García-Foncillas, et. al.J García-Foncillas ... A Stenzinger
01 May 2024
Re: Parker CC, Petersen PM, Cook AD, et al. Timing of radiotherapy (RT) after radical prostatectomy (RP): long-term outcomes in the RADICALS-RT trial [NCT00541047]. Ann Oncol. 2024 Apr 5:S0923-7534(24)00105-4
Elio Mazzone ... Francesco Montorsi
Annals of Oncology | VOL. -
Elio Mazzone, et. al.Elio Mazzone ... Francesco Montorsi
01 May 2024
Table of Contents
-
Annals of Oncology | VOL. 35
--
01 May 2024
View more papers